The impact of the COVID-19 outbreak on supportive care for oral mucositis: current concepts and practice
Tóm tắt
The outbreak of coronavirus disease 2019 (COVID-19) markedly affected the way healthcare professionals approach patients with cancer worldwide, not only in terms of therapeutic decision-making but also in terms of supportive care. With the rapid appearance of signs and symptoms and the need of close re-assessment, standard management of oral mucositis has been challenged by physical distancing and limited resources due to the global crisis. Building on the clinical experience developed during the acute phase by members of the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO), the implications of COVID-19 on the prevention, assessment, and treatment of mucositis are critically reported. Inspired by the restructuring of supportive care measures in response to the pandemic, suggestions for new models of approaching acute side effects are also discussed.
Tài liệu tham khảo
Ando M, Ando Y, Hasegawa Y, Shimokata K, Minami H, Wakai K, Ohno Y, Sakai S (2001) Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-smallcell lung cancer. Br J Cancer 85:1634–1639. https://doi.org/10.1054/bjoc.2001.2162
Karvonen-Gutierrez CA, Ronis DL, Fowler KE, Terrell JE, Gruber SB, Duffy SA (2008) Quality of life scores predict survival among patients with head and neck cancer. J Clin Oncol 26:2754–2760. https://doi.org/10.1200/JCO.2007.12.9510
Marandino L, Necchi A, Aglietta M, di Maio M (2020) COVID-19 emergency and the need to speed up the adoption of electronic patient-reported outcomes in cancer clinical practice. JCO Oncol Pract 16:295–298. https://doi.org/10.1200/OP.20.00237
Stiff PJ, Erder H, Bensinger WI, Emmanouilides C, Gentile T, Isitt J, Lu ZJ, Spielberger R (2006) Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT). Bone Marrow Transplant 37:393–401
Sandler KA, Mitchell SA, Basch E, Raldow AC, Steinberg ML, Sharif J, Cook RR, Kupelian PA, McCloskey SA (2018) Content validity of anatomic site-specific patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) item sets for assessment of acute symptomatic toxicities in radiation oncology. Int J Radiat Oncol Biol Phys 102(1):44–52
Eggers M, Koburger-Janssen T, Eickmann M, Zorn J (2018) In vitro bactericidal and virucidal efficacy of povidone-iodine gargle/mouthwash against respiratory and oral tract pathogens. J Infect Dis Ther 7:249–259. https://doi.org/10.1007/s40121-018-0200-7
Eggers M, Eickmann M, Zorn J (2015) Rapid and effective virucidal activity of povidone-iodine products against Middle East respiratory syndrome coronavirus (MERS-CoV) and modified vaccinia virus Ankara (MVA). J Infect Dis Ther 4:491–501
Kawana R, Kitamura T, Nakagomi O et al (1997) Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. Dermatology 195(Suppl 2):29–35
Bernstein D, Schiff G, Echler G, Prince A, Feller M, Briner W (1990) In vitro virucidal effectiveness of a 0.12%-chlorhexidine gluconate mouthrinse. J Dent Res 69:874–876. https://doi.org/10.1177/00220345900690030901
Hong CHL, Gueiros LA, Fulton JS et al (2019) Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer 27:3949–3967. https://doi.org/10.1007/s00520-019-04848-4
Al-Shamsi HO, Alhazzani W, Alhuraiji A et al (2020) A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an international collaborative group. Oncologist 25:e936–e945. https://doi.org/10.1634/theoncologist.2020-0213
Day AT, Sher DJ, Lee RC, Truelson JM, Myers LL, Sumer BD, Stankova L, Tillman BN, Hughes RS, Khan SA, Gordin EA (2020) Head and neck oncology during the COVID-19 pandemic: reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks. Oral Oncol 105:104684. https://doi.org/10.1016/j.oraloncology.2020.104684
Lou E, Beg S, Bergsland E, Eng C, Khorana A, Kopetz S, Lubner S, Saltz L, Shankaran V, Zafar SY (2020) Modifying practices in GI oncology in the face of COVID-19: recommendations from expert oncologists on minimizing patient risk. JCO Oncol Pract 16:383–388. https://doi.org/10.1200/OP.20.00239
Elad S, Cheng K, Lalla RV et al (2020) The MASCC/ISSO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 2020:4423–4431. https://doi.org/10.1002/cncr.33100
Faria KM, Gomes-Silva W, Kauark-Fontes E et al (2020) Impact of pandemic COVID-19 outbreak on oral mucositis preventive and treatment protocols: new perspectives for extraoral photobiomodulation therapy. Support Care Cancer 21:1–4
Treister NS, London WB, Guo D, Malsch M, Verrill K, Brewer J, Margossian S, Duncan C (2016) A feasibility study evaluating extraoral photobiomodulation therapy for prevention of mucositis in pediatric hematopoietic cell transplantation. Photomed Laser Surg 34:178–184. https://doi.org/10.1089/pho.2015.4021
Prasad A, Brewster R, Newman JG, Rajasekaran K (2020) Optimizing your telemedicine visit during the COVID-19 pandemic: practice guidelines for patients with head and neck cancer. Head Neck 42:1317–1321. https://doi.org/10.1002/hed.26197
Pollock K, Setzen M, Svider PF (2020) Embracing telemedicine into your otolaryngology practice amid the COVID-19 crisis: an invited commentary. Am J Otolaryngol 41:102490. https://doi.org/10.1016/j.amjoto.2020.102490
Murrell M, Marchini L, Blanchette D et al (2019) Intraoral camera use in a dental school clinic: evaluations by faculty, students, and patients. J Dent Educ 83:1339–1344. https://doi.org/10.21815/JDE.019.140